Diagnostic Accuracy of p16 INK4a /Ki‐67 Dual Immunostaining for Detection of High‐Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia
Analytical Cellular Pathology · 2023
DOI: 10.1155/2023/7988323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2023. Verfasst von Sopio Kakaliashvili-Dzagnidze und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pathology and Pharmacology Research Department, Medical school, Georgian American University, Tbilisi 0160, Georgia. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Despite the widespread introduction of primary and secondary preventative measures, death rates for cervical cancer are still significantly high among females, especially in developing countries. Pap cytology and human papillomavirus‐based screening often lead to unnecessary additional testing. The aim of this study is to analyze diagnostic accuracy of p16 INK4a /Ki‐67 dual immunostaining (DS) in cervical smear for identifying high‐grade cervical intraepithelial neoplasia (CIN2+). Materials and Methods . We studied the diagnostic performance of p16 INK4a /Ki‐67 DS in cervical smear of those women, who enrolled in cervical cancer screening due to abnormal previous screening results and compared it with Pap test results in identifying CIN2+. The reference standard was histopathology results. p16 INK4a /Ki‐67 DS and Pap test results for 162 women and histopathology results for 29 women were available, respectively.
Results
In our study, sensitivity, specificity, positive predictive value, and negative predictive value of p16 INK4a /Ki‐67 DS, irrespective of the morphology of stained cells to detect CIN2+ were 100%, 89%, 85%, and 100% ( p < 0.01), respectively. The diagnostic accuracy of p16 INK4a /Ki‐67 DS is superior to that of existing cervical screening tests in the detection of CIN2+.
Conclusion
The findings of cervical cancer screening based on Pap cytology highlight the importance of assessing the cost‐effectiveness of integrating p16 INK4a /Ki‐67 biomarkers in cervical cancer cytology. Furthermore, these findings emphasize the need to enhance support for preventive programs for cervical cancer in Georgia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathology and Pharmacology Research Department, Medical school, Georgian American University, Tbilisi 0160, Georgia.
- David Tvildiani Medical University, Tbilisi 0159, Georgia.
- Department of Anatomic Pathology, Faculty of Medicine, Tbilisi State Medical University, Tbilisi 0186, Georgia.
ORCID-Profile: Sopio Kakaliashvili-Dzagnidze
Zitieren
APA
Kakaliashvili-Dzagnidze, S., Khardzeishvili, O., & Tabagari, S. (2023). Diagnostic Accuracy of p16 INK4a /Ki‐67 Dual Immunostaining for Detection of High‐Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia. Analytical Cellular Pathology. https://doi.org/10.1155/2023/7988323
Vancouver
Kakaliashvili-Dzagnidze S, Khardzeishvili O, Tabagari S. Diagnostic Accuracy of p16 INK4a /Ki‐67 Dual Immunostaining for Detection of High‐Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia. Analytical Cellular Pathology. 2023. doi:10.1155/2023/7988323
BibTeX
@article{KakaliashviliDzagnidze2023,
author = {Kakaliashvili-Dzagnidze, Sopio and Khardzeishvili, Omar and Tabagari, Sergo},
title = {Diagnostic Accuracy of p16 INK4a /Ki‐67 Dual Immunostaining for Detection of High‐Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia},
journal = {Analytical Cellular Pathology},
year = {2023},
doi = {10.1155/2023/7988323}
}
EUVIMED